PUVA for cutaneous T-cell lymphoma. 10 years after.
D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy* / Q000473:pathology; D009364:Neoplasm Recurrence, Local; D011701:PUVA Therapy / Q000009:adverse effects; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D013601:T-Lymphocytes / Q000187:drug effects / Q000528:radiation effects